Injectafer Linked to Severe Hypophosphatemia
Recent research has shown that using Injectafer, a prescription medication for patients with insufficient iron levels could cause a severe case of hypophosphatemia (HPP). This disorder can lead to coma, seizures and death if not treated. And although the U.S. Food and Drug Administration (FDA)…